TFS was founded in 1996 and has grown to become the leading global mid-size clinical CRO focusing on small and mid-size life science customers. TFS employs more than 700 professionals throughout 21 countries and currently delivers clinical research services in more than 40 countries. We can provide end-to-end solutions or flexible single services. Our partnering approach with customers is based on our four business principles – commitment, flexibility, value creation and global reach. Our core therapeutic specialties are Oncology, Immunology, Dermatology, Ophthalmology, CNS, Cardiology and Endocrinology.
Detailed information about TFS, our business offerings, global locations and recent press releases can be obtained through www.tfscro.com